Tuberculosis Medications Program
The Minnesota Department of Health (MDH) Tuberculosis (TB) Prevention and Control Program provides TB medications free of charge for persons with latent TB infection (LTBI) or active TB disease who reside in Minnesota. Treatment regimens using medications supplied by MDH must follow the Centers for Disease Control and Prevention/American Thoracic Society/Infectious Diseases Society of America guidelines for treatment of LTBI or treatment of active TB disease.
To request medications for the treatment of LTBI, the provider should
contact the MDH TB Medications Coordinator at 651-201-5414 or 1-877-676-5414.
The provider will be asked to provide pertinent demographic and clinical information and a copy of the prescription(s).
|TB Medications Coordinator
MDH TB Prevention and Control Program
Minnesota Department of Health
P.O. Box 64975
St. Paul, MN 55164-0975
Please note that all requests for the 12-Week INH-RPT Regimen must be accompanied by a completed Individual Plan for Using the Isoniazid and Rifapentine (INH-RPT) Regimen (PDF). As of August 28, 2015 there is a shortage of Rifapentine from our supplier. The expected end date is mid-October 2015. Until supply levels return to normal, MDH will not fill orders for the INH-RPT regimen. Check back to this site for further updates. This message will be deleted when supply levels have returned to normal. Contact the MDH TB Medications Coordinator if you have questions.
MDH (through its contracted pharmacy) will ship the patient's first month supply of LTBI medication to the designated clinic or local public health agency (or other provider licensed to administer medications) within 5 working days of when the request form is received. If the form is incomplete or the request is not consistent with national LTBI treatment guidelines (PDF), the shipment may be delayed.
After treatment starts, complete and return the LTBI Medication Start Date Verification Form (PDF) that was included with the first shipment to fax number 651-201-5500 or mail to the above address. Upon receiving this verification, MDH will ship monthly refills until treatment is complete. If treatment is discontinued for any reason or patient is lost to follow-up, please contact MDH ASAP to stop shipments.
The health care professional who receives the medication shipments is responsible for monitoring the patient for adverse reactions and for adherence to the regimen. The timing and type of monitoring activities should be done according to CDC guidelines for each regimen. An updated LTBI: Monitoring Flow Sheet (PDF) that includes the new isoniazid-rifapentine (INH-RPT) regimen is available from MDH to assist with this process.
- LTBI Dosing: INH (PDF)
Quick-reference dosing table for LTBI medication.
- Treatment of Latent Tuberculosis Infection: Maximizing Adherence (PDF)
Fact sheet from the Centers for Disease Control and Prevention (CDC) that presents practical techniques for increasing patient adherence to LTBI treatment. Please contact MDH staff for additional guidance.
- Interjurisdictional Tuberculosis Notification Form (PDF)
Designed by the National TB Controllers Association to standardize the transfer of TB clients. Please consult with MDH TB staff before completing this form.
To request medications for treatment of active TB disease, the provider should contact the MDH TB Nurse Case Manager at 651-201-5414 or 1-877-676-5414. The provider will be asked to provide pertinent clinical and demographic information and a copy of the prescription(s).
Medications will be sent monthly to the designated clinic, local public health agency, or other provider licensed to administer medications.
If a patient being treated for active TB disease stops therapy,
fails to pick up medications, or if treatment is discontinued,
please contact the MDH TB Nurse Case Manager immediately.